|
|
|
|
|
Synergistic Effect of Combining MLC601 and Rehabilitation on Post-Stroke Recovery: The Chimes-E Study |
2560 |
# |
|
|
|
|
|
Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations |
2565 |
# |
|
|
|
|
|
Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates |
2553 |
# |
|
|
|
|
|
Symptomatic spontaneous vertebrobasilar dissections in children: review of 29 consecutive cases Clinical article |
2553 |
# |
|
|
|
|
|
Symptomatic Dermographism: A Systematic Review of Treatment Options |
2563 |
# |
|
|
|
|
|
Symptom Experience, Symptom Management Strategies, and Health Related Quality of Life among People with Heart Failure |
2564 |
# |
|
|
|
|
|
Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck |
2550 |
# |
|
|
|
|
|
Switching from high-efficacy lipid-lowering therapies [atorvastatin or rosuvastatin] to simvastatin and the results on low-density lipoprotein cholesterol level |
2558 |
# |
|
|
|
|
|
Switching from heparinized saline flush to normal saline flush for maintaining peripheral venous catheter patency. |
2549 |
# |
|
|
|
|
|
Switching efavirenz to rilpivirine in virologically suppressed adolescents with HIV: a multi-centre 48-week efficacy and safety study in Thailand |
2565 |
# |
|
|
|
|
|
Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns |
2565 |
# |
|
|
|
|
|
Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma |
2557 |
# |
|
|
|
|
|
Sw2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease |
2553 |
# |
|
|
|
|
|
SUSTAINED VIROLOGICAL RESPONSE OF ANTIVIRAL THERAPY AND CLINICAL OUTCOMES IN ELDERLY PATIENTS WITH COMPENSATED HCV-RELATED CIRRHOSIS |
2553 |
# |
|
|
|
|
|
Sustained replication of dengue pseudoinfectious virus lacking the capsid gene by trans-complementation in capsid-producing mosquito cells |
2556 |
# |
|
|
|
|
|
Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection: Final Results of a Randomized, Controlled, Phase II Study (Protocol 004) |
2555 |
# |
|
|
|
|
|
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection |
2552 |
# |
|
|
|
|
|
Sustainable, affordable and functional: reimagining prosthetic liners in resource limited environments |
2563 |
# |
|
|
|
|
|
Sustainable Development: A Below-Knee Prostheses Liner for Resource Limited Environments |
2563 |
# |
|
|
|
|
|
SUSTAINABILITY OF INTEGRATED CKD CARE ON RENAL OUTCOMES: A 5-YEAR FOLLOW-UP ON THE ESCORT-1 TRIAL. |
2564 |
# |
|
|
|
|
|
Suspected Mycoplasma Contamination in the Study "Toll-Like Receptor 2 Recognizes Orientia tsutsugamushi and Increases Susceptibility to Murine Experimental Scrub Typhus" |
2560 |
# |
|
|
|
|
|
Susceptibility of human and avian influenza viruses to human and chicken saliva |
2557 |
# |
|
|
|
|
|
Survivorship of medial opening wedge high tibial osteotomy in the elderly: two to ten years of follow up. |
2560 |
# |
|
|
|
|
|
SURVIVORSHIP CARE PLAN IN PROSTATE CANCER |
2555 |
# |
|
|
|
|
|
Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. |
2545 |
# |
|
|
|
|
|
Survival Times of Patients with a First Hip Fracture With and Without Subsequent Major Long-Bone Fractures |
2556 |
# |
|
|
|
|
|
Survival outcomes of metastatic/unresectable hepatocellular carcinoma in patients treated with sorafenib |
2562 |
# |
|
|
|
|
|
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients |
2563 |
# |
|
|
|
|
|
Survival outcomes for transarterial radioembolization with Y-90 glass microspheres in hepatocellular carcinoma patients: a single-institution experience |
2562 |
# |
|
|
|
|
|
Survival outcome of combined gnrh agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer |
2562 |
# |